News
Since 2020, patients from all over the world—including nearly 60% traveling from outside the United States—have sought Dr.
Folicure's guide underscores the importance of early action and informed decision-making in tackling hair loss. It aims to empower readers to take the first step toward rediscovering their confidence ...
ORPATHYS ® is an oral, potent and highly selective MET tyrosine kinase inhibitor (“TKI”) being jointly developed by AstraZeneca and HUTCHMED and commercialized by AstraZeneca. TAGRISSO ® is a ...
Floridians can now visit newbeingnutrition.com to find vetted local specialists and take control of their chronic care ...
Webcasts for these conferences may be accessed at the “Events” section of the Company’s website. A replay of these webcasts will be available on the Arcutis website for 180 days following the ...
Sandy Eulitt, CEO and Founder of Life Backup Plan by Galacxia, Inc. The feature will broadcast on Fox Business Network and ...
Colon Broom, now featuring its cutting-edge ColonBroom GLP-1 Booster formula, was created with a singular mission: to help ...
The SmartVascular Dx test is essential for the early detection of vascular disease, which is a significant health concern in many communities. Its capabilities enable timely and targeted interventions ...
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza ...
The financing consists of a combination of a $36 million line of credit and a $14 million contingent private placement. The line of credit is available immediately and allows Tevogen Bio to access up ...
NMDP Unite brings together blood stem cell donors, transplant recipients, caregivers, and supporters, all united by one mission: to find cures and give hope to patients facing life-threatening blood ...
Investment to support NovaBay’s continued public listing and provide funding for a future strategic transaction ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results